CGC Financial Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-5
| Closed | -$406 | – | 352 |
|
2025
Q1 | $406 | Hold |
5
| – | – | ﹤0.01% | 314 |
|
2024
Q4 | $450 | Hold |
5
| – | – | ﹤0.01% | 320 |
|
2024
Q3 | $494 | Hold |
5
| – | – | ﹤0.01% | 313 |
|
2024
Q2 | $464 | Hold |
5
| – | – | ﹤0.01% | 319 |
|
2024
Q1 | $474 | Hold |
5
| – | – | ﹤0.01% | 324 |
|
2023
Q4 | $446 | Hold |
5
| – | – | ﹤0.01% | 337 |
|
2023
Q3 | $365 | Hold |
5
| – | – | ﹤0.01% | 307 |
|
2023
Q2 | $416 | Buy |
+5
| New | +$416 | ﹤0.01% | 326 |
|